About the OHA Beteiligungsgesellschaft
The OHA Beteiligungs GmbH is a 50% shareholder and the investment arm of OHA Accelerator GmbH, which now consists of 38 shareholders.
The OHA Osnabrück Healthcare Beteiligungs GmbH provides venture capital for startups within the OHA and beyond. It comprises 38 entrepreneurs from the Osnabrück economic region who pool capital, experience and networks to establish and scale innovative startups in the healthcare sector. The managing director of the investment company is Jan-Felix Simon, who is also the managing director of our co-partner Mölk Management GmbH from Osnabrück.
How does the OHA BTG invest?
The OHA Beteiligungs GmbH supports the accelerator with €50,000 per year and provides up to €150,000 for direct investments per startup investment. In addition, direct investments from our circle of shareholders are also possible. From the supported startups, we select teams that offer scalable business models, sustainable impact in the healthcare sector and a convincing founding team with strong implementation skills.
Die OHA Beteiligungs GmbH fördert den Accelerator mit 50.000 € pro Jahr und stellt bis zu 150.000 € für direkte Beteiligungen pro Startup-Investment bereit. Darüber hinaus sind auch Direktinvestments aus ihrem Gesellschafterkreis möglich. Aus den geförderten Startups wählen wir die Teams aus, die skalierbare Geschäftsmodelle, nachhaltige Wirkung im Gesundheitswesen und ein überzeugendes Gründerteam mit Umsetzungsstärke mitbringen.
How is the OHA BTG financed?
The investment company currently has 38 shareholders. The company is financed through three share classes (Junior Share, Regular Share and Premium Share) with graduated investment rights. However, voting rights are the same regardless of the share class – the focus is on cooperation and the joint advancement of the OHA, rather than on the enforcement of particular interests.
What makes us special
Our core concern is not only to finance founders, but also to provide them with professional and personal support in a complex and regulated market.
Our USP:
- clear focus on healthcare and health tech
- concentrated entrepreneurial expertise from practice, industry, IT and finance
- Personal access to decision-makers in the healthcare market
We do not invest anonymously, but work together with the teams on an equal footing – with short communication channels, honest feedback and a dedicated network that opens doors.
Our focus: Healthcare market & health tech
Our shareholders come from, among others:
- Machinery and equipment manufacturing for pharmaceutical companies, laboratories and medical practices
- Development, manufacture and distribution of medical technology, medicines and medical aids
- Established service providers and medical facilities
This industry knowledge is complemented by young companies and experts from the following fields:
- VR/AR
- Artificial Intelligence
- Digital health, app and software development
- Digital content and mobile screens
- Finance, law, marketing & consulting
- Tax and (medical) legal advice
- Management consulting and IT
This enables us to support start-ups early on in the development of their solutions – from the initial idea to the market-ready application – and to support fast-growing start-ups with their stable processes.
The Shareholders
_colour_150ppi_transparent.png){kind=spacer}
Investment Portfolio
Reesi
Less research, more time for patients — Reesi replaces hours of registry research with one click — reliable information, within seconds
Hellstern Medical
With the intelligent, sensor-controlled RoboCockpit from noac, Hellstern enables effective and cost-effective collaboration between humans and machines.
Hellomed
Digitalized pharmacy care from care glasses: Highest quality of care every day, prescriptions on autopilot, delivery to the door, always MD compliant. 100% specialized in outpatient and inpatient care facilities.
Avelios Medical
Avelios offers a cutting-edge HIS of the future: With treatment process-oriented digitization, modular microservices platform & fully structured data.
Meliodays Medical
meliodays develops MelioOne, the first hormone-free coil with integrated pain reliever to relieve period pain. MelioOne fights inflammation in the uterus directly and thus enables effective pain relief without affecting the natural cycle. Thanks to local use, the dose remains minimal and works without systemic side effects. Our goal: to sustainably improve women's quality of life and to make healthcare more equitable.
LipoCheck
LipoCheck focuses on improving the diagnosis and treatment of lipedema, which affects every tenth woman. The startup offers an AI-powered healthcare platform that provides comprehensive support throughout the patient journey. The platform uses unique data, knowledge, and an international network to show and provide patients with care routes.
Lillian Care
Medical care, particularly in rural regions, is facing an acute and growing challenge due to the shortage of doctors. Lillian Care is taking on this challenge and is opening new practices for general medicine right there. In hybrid practices, the treatment is carried out jointly by nurse/ physician assistants and doctors, which significantly relieves doctors and allows them to work remotely. Modern technology and new work for female employees also play an important role.
Family Cards
Family.cards expands the biggest screen in the house for seniors — the television — so that digital services can be used via it. With its revolutionary haptic interface, family.cards enables seniors to connect, share memories and stay in touch with loved ones and access health services. With video calls, photo sharing, entertainment content, telemedicine, exercise and wellness, the founders bridge the generational gap.
MindaHead
MindAhead aims to provide early detection and intervention for cognitive impairment through an AI-driven assessment and tracking tool and a digital brain health therapy program. Because while dementia is often only diagnosed when there are only a few therapeutic options left, all stages before the onset of dementia, such as mild cognitive impairment (MCI — mild cognitive impairment), are only insufficiently diagnosed.
Ankaadia
Ankaadia's team has developed a software solution that digitizes the process of recruiting, recognizing and integrating international specialists. It is designed for recruitment agencies and employers to make the employment migration of international specialists transparent and easy. It connects all parties involved on one platform and enables digital and GDPR-compliant collaboration.
Our Advisory Board Members
Prof. Dr. med. Jörg Heckenkamp
Chief Physician Vascular Surgery Marienhospital Osnabrück
.jpg)
Ulrich Wallenhorst
CEO, zwei.7
Marc Liepe
LM IT Services AG
Henrik Oevermann
Hubertus Invest GmbH
Dr. med. Erik Beeke
visualeins, Chairman of the Advisory Board of the BTG
Voices from the Advisory Board
As an investment company of the OHA Osnabrück Healthcare Accelerator, we combine up to 150,000 euros in growth capital with the experience of 38 entrepreneurs from the healthcare sector. We open doors for startups to clinics, practices, industry and financing partners and personally support them from the early phase to scaling. This combination of capital, specialized industry knowledge and an active network makes us the ideal partner of currently 11 startups in the healthcare sector.
Jan-Felix Simon
Managing Director OHA Beteiligungs GmbH
As a member of the Advisory Board of Osnabrück Healthcare Beteiligungs GmbH, I support innovative founders on their journey from an idea to a marketable healthcare company. The OHA connects start-ups with experienced partners and offers not only technical support but also targeted investment opportunities — creating an environment in which innovations really grow.
Henrik Oevermann
Hubertus Invest GmbH
As a member of the Advisory Board of Osnabrück Healthcare Beteiligungs GmbH, I support innovative founders on their journey from an idea to a marketable healthcare company. The OHA connects start-ups with experienced partners and offers not only technical support but also targeted investment opportunities — creating an environment in which innovations really grow.
Henrik Oevermann
Hubertus Invest GmbH
As an investment company of the OHA Osnabrück Healthcare Accelerator, we combine up to 150,000 euros in growth capital with the experience of 38 entrepreneurs from the healthcare sector. We open doors for startups to clinics, practices, industry and financing partners and personally support them from the early phase to scaling. This combination of capital, specialized industry knowledge and an active network makes us the ideal partner of currently 11 startups in the healthcare sector.
Jan-Felix Simon
Managing Director OHA Beteiligungs GmbH
Shall we grow together?
We would like to expand our network in a targeted manner. If you would like to support female entrepreneurs in the healthcare sector – and are willing to do so not only financially but also personally – we would be delighted to hear from you. Our managing director, Jan-Felix Simon, will be happy to provide you with further information and meet you in person.
Social
lingua
© OHA 2025. All rights reserved.
